Form 4: Amedisys Inc. Chief Accounting Officer Reports Stock Sale
SEC Form 4 Filing
Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reports the sale of 374 shares of common stock at $96 per share on May 8, 2025.
Summary
- On May 8, 2025, Allyson Guidroz, the Chief Accounting Officer of Amedisys Inc., sold 374 shares of common stock at a price of $96 per share.
- Following the transaction, Guidroz directly owns 8,114 shares of Amedisys Inc. common stock.
- Guidroz also indirectly owns 1.5 shares of common stock through a 401(k) plan, based on a plan statement dated March 31, 2025.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to a stock sale by a company insider. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like the Chief Accounting Officer in this case, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Comparing this transaction to industry standards requires analyzing similar Form 4 filings from peer companies in the healthcare services sector, such as LHC Group or Option Care Health.
- The size of the transaction (374 shares) and the remaining holdings (8,114 shares) can be benchmarked against typical insider ownership levels in comparable firms.
- Analyzing the timing of the transaction relative to earnings releases or other significant company events would provide further context.
Stakeholder Impact
- The stock sale by a key officer could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons behind the sale.
- The impact is likely minimal unless the sale is part of a larger trend of insider selling.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of the 401(k) plan statement used for reporting indirect ownership. |
| 05/08/2025 | Date of the stock sale transaction. |
| 05/09/2025 | Date of signature on the Form 4 filing. |
Keywords
Amedisys Inc, Allyson Guidroz, Chief Accounting Officer, Form 4, Stock Sale, Beneficial Ownership, AMED, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.